XBiotech Inc. (NASDAQ: XBIT) is a Healthcare company (Biotechnology) with a market capitalization of $54M. The Maz Rating grades it against the other companies in its sector.
XBiotech Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $1.78, XBiotech Inc. trades at 0.4x book value, with an EV/EBITDA of 1.3. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -33.0%, return on invested capital of -37.7% and a free cash flow yield of -75.6%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 39.51. Over the past 52 weeks the share price ranged from $1.78 to $2.73, with a beta of 0.74.
XBiotech Inc. does not currently pay a dividend.
3 Wall Street analyst ratings cover the stock: 3 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.